Clinical Trial Update: 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of 18F-DOPA PET to understand how lurasidone may exert antidepressant effects in bipolar depression; results posted after complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED | Results posted: 2020-10-06